New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

Adaptive Reaches 50 Publications

Adaptive’s technology propels research forward in oncology, hematology, infectious disease, transplantation, and autoimmunity, enabling a paradigm shift in understanding human immunology.